Skip to main content

Policy Issues in the Development of Personalized Medicine in Oncology Workshop Summary (2010) / Chapter Skim
Currently Skimming:

Acronyms
Pages 71-72

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 71...
... Acronyms ACCE Analytic validity; Clinical validity; Clinical utility; and Ethical, legal, and social implications AHRQ Agency for Healthcare Research and Quality AML acute myelogenous leukemia ASCO American Society of Clinical Oncology CALGB Cancer and Leukemia Group B CAP College of American Pathologists CDC Centers for Disease Control and Prevention CDRH Center for Devices and Radiological Health CF cystic fibrosis CHOP cyclophosphamide, doxorubicin, vincristine, prednisone therapy CLIA Clinical Laboratory Improvement Amendments CMS Centers for Medicare & Medicaid Services CPT current procedural terminology EGAPP Evaluation of Genomic Applications in Practice and Prevention EGFR epidermal growth factor receptor EMEA European Medicines Agency ER estrogen receptor 
Read the entire page →
From page 72...
... Preventive Services Task Force
Read the entire page →

Key Terms

  • preventive services
  • services task


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.